LC
PFE icon

Lavaca Capital’s Pfizer PFE Stock Holding History

Lavaca Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,000
Closed -$326K – 172
2021
Q1 		$326K Buy
+9,000
New +$320K 0.03% 107

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lavaca Capital's PFE Position: Q1 2026 in Review

Lavaca Capital increased its Pfizer (PFE) stake by 6% in Q1 2026, buying an estimated $17K and bringing the position to 11,267 shares worth $316K. The position accounts for 0.06% of the portfolio, ranked #85.

Lavaca Capital first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.44M in Q1 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Lavaca Capital held 11,267 shares of Pfizer worth $316K as of Q1 2026.
  • Lavaca Capital bought 639 Pfizer shares in Q1 2026, an estimated $17K.
  • Pfizer made up 0.06% of Lavaca Capital's portfolio in Q1 2026, its #85 holding.
  • Lavaca Capital first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
  • Lavaca Capital's Pfizer position peaked at $2.44M in Q1 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Lavaca Capital's 13F filing for Q1 2026, filed 13 May 2026.